CSF BACE1 activity is increased in CJD and Alzheimer disease other dementias

Neurology

Volumn 67, Issue 4, 2006, Pages 710-712

  Holsinger, R M D ^a,b,d   Lee, J S ^a,c   Boyd, A ^a,c   Masters, C L ^a,b,c   Collins, S J ^a,b,c  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^c Australian National Creutzfeldt Jakob Disease Registry   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BETA SECRETASE;

AGED; ALZHEIMER DISEASE; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; DEMENTIA; DIAGNOSTIC PROCEDURE; ENZYME ACTIVITY; ENZYME ANALYSIS; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

14-3-3 PROTEINS; AGED; ALZHEIMER DISEASE; AMYLOID PRECURSOR PROTEIN SECRETASES; ASPARTIC ENDOPEPTIDASES; AUSTRALIA; BIOLOGICAL MARKERS; CREUTZFELDT-JAKOB SYNDROME; DEMENTIA; DIAGNOSIS, DIFFERENTIAL; ENDOPEPTIDASES; ENZYME ACTIVATION; FEMALE; HUMANS; MALE; NERVE TISSUE PROTEINS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TAU PROTEINS;

EID: 33747659600     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000229925.52203.4c     Document Type: Article

References (10)

1. Selkoe DJ. Cell biology of protein misfolding: the examples of Alzheimer's and Parkinson's diseases. Nat Cell Biol 2004;6:1054-1061.
2. Holsinger RMD, Mclean CA, Beyreuther K, Masters CL, Evin G. Increased expression of the amyloid precursor β-secretase in Alzheimer's disease. Ann Neurol 2002;51:783-786.
3. Holsinger RMD, McLean CA, Collins SJ, Masters CL, Evin G. Increased β-secretase activity in cerebrospinal fluid of Alzheimer's disease subjects. Ann Neurol 2004;55:898-899.
4. Collins SJ, Boyd A, Fletcher A, et al. Novel prion protein gene mutation in an octogenarian with Creutzfeldt-Jakob disease. Arch Neurol 2000; 57:1058-1063.
5. Kapaki E, Kilidireas K, Paraskevas GP, Michalopoulou M, Patsouris E. Highly increased CSF tau protein and decreased β-amyloid (1-42) in sporadic CJD: a discrimination from Alzheimer's disease? J Neurol Neurosurg Psychiatry 2001;71:401-403.
6. 1-42 in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. Neurology 2000;54:1099-1102.
7. Green AJ. Cerebrospinal fluid brain-derived proteins in the diagnosis of Alzheimer's disease and Creutzfeldt-Jakob disease. Neuropathol Appl Neurobiol 2002;28:427-440.
8. Galasko D, Clark C, Chang L, et al. Assessment of CSF levels of tau protein in mildly demented patients with Alzheimer's disease. Neurology 1997;48:632-635.
9. Arai H, Morikawa Y, Higuchi M, et al. Cerebrospinal fluid tau levels in neurodegenerative diseases with distinct tau-related pathology. Biochem Biophys Res Commun 1997;236:262-264.
10. Blennow K, Wallin A, Agren H, Spenger C, Siegfried J, Vanmechelen E. Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer's disease? Mol Chem Neuropathol 1995;26: 231-245.